Skip to content

Study · Non-randomized trial · 2026

1 result

Resting state functional connectivity in paedophilic disorder and degarelix treatment.

Andersson L, Mannfolk C, Ljungberg M, Liberg B, Rahm C, Björkman-Burtscher IM

Acta neuropsychiatrica1 Apr 2026

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: CC BY-NC. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In paedophilic disorder, follow-up analyses found no significant functional connectivity alterations related to degarelix after FDR correction.

    In plain wordsIn patients with paedophilic disorder, degarelix showed no significant brain connectivity changes versus placebo after correction for multiple comparisons.

    Peptide
    Degarelix
    Outcome
    No significant changeResting state functional connectivity
    Study

    n: not reported in source

    Comparator
    Placebo
    Outcome group
    Receptor activity and mechanism · Nervous system and cognition
    Studied dose
    Dose not stated · injectionAs given in this study (human).

    Source sentences

    Summary
    At follow-up time points, however, group comparisons were inconclusive and did after FDR correction not render statistically significant FC alterations when comparing patients to controls or related to degarelix treatment, CSA dynamic risk scores or comorbidities.
    1 context sentence
    Summary · context
    We used independent component analysis on resting state (rs)fMRI data acquired at baseline as well as two and ten weeks after injection of degarelix (or placebo) to evaluate FC alterations related to PeD and the degarelix treatment effect.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    28 Oct 2026, 02:03 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:34 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.